experiment
model
humor
immun
critic
protect
wnvmediat
diseas
bennathan
et
al
camenga
et
al
diamond
et
al
b
engl
diamond
gould
et
al
tesh
et
al
wang
et
al
b
celldefici
mice
suscept
diseas
diamond
et
al
halevi
et
al
passiv
transfer
antibodi
mice
restor
immun
engl
diamond
clinic
case
report
describ
use
human
intraven
immunoglobulin
ig
contain
wnv
antibodi
patient
neurolog
diseas
suggest
therapeut
benefit
haley
et
al
hamdan
et
al
shimoni
et
al
placebocontrol
clinic
trial
progress
determin
valid
observ
http
clinicaltrialsgovhtm
analysi
humor
respons
wnv
mainli
carri
experiment
infect
rodent
oliph
et
al
sanchez
et
al
isol
monoclon
antibodi
mab
panel
use
determin
antigen
variabl
wnv
challeng
studi
perform
test
vaccin
clinic
develop
classic
human
antibodi
respons
wnv
infect
studi
look
serolog
respons
infect
recent
advanc
protein
engin
approach
display
technolog
util
probe
human
repertoir
wnv
collect
studi
identifi
import
differ
humor
respons
natur
wnv
infect
human
compar
experiment
wnv
infect
rodent
particular
persist
wnvspecif
igm
infect
immunodomin
weakli
neutral
epitop
domain
ii
region
eprotein
appear
uniqu
human
immun
respons
wnv
differ
potenti
import
consequ
design
test
prevent
vaccin
sourc
human
wnv
infect
almost
invari
bite
infect
mosquito
although
transmiss
rout
transplant
blood
transfus
report
iwamoto
et
al
initi
replic
wnv
inocul
thought
occur
dendrit
cell
skin
migrat
secondari
lymphoid
tissu
replic
viru
enter
circul
byrn
et
al
viremia
transient
low
titer
viru
typic
detect
revers
transcriptas
polymeras
chain
reaction
rtpcr
base
assay
day
post
infect
lanciotti
et
al
symptom
gener
appear
time
viremia
disappear
viru
becom
detect
cerebr
spinal
fluid
csf
period
wnv
detect
csf
variabl
last
sever
week
patient
often
correl
sever
symptom
clinic
cours
rang
selflimit
febril
diseas
sever
neuroinvas
diseas
lead
perman
disabl
death
klee
et
al
serolog
surveil
data
new
york
epidem
show
one
five
peopl
infect
wnv
develop
fever
develop
neurolog
symptom
mostashari
et
al
data
support
subsequ
seropreval
studi
suggest
human
wnv
infect
result
signific
symptom
busch
et
al
risk
factor
sever
diseas
well
defin
apart
age
individu
age
increas
risk
develop
sever
diseas
hypertens
diabet
also
causal
associ
seriou
wnv
diseas
granwehr
et
al
patient
suspect
wnv
infect
test
presenc
igm
igg
antibodi
wnv
use
commerci
avail
igmcaptur
enzymelink
immunosorb
assay
elisa
indirect
igg
elisa
respect
case
diagnosi
wnv
infect
confirm
definit
plaqu
reduct
neutral
assay
prnt
howev
prnt
assay
specif
wnv
requir
special
laboratori
facil
routin
perform
reason
serolog
data
relat
human
wnv
infect
base
elisa
experi
alon
give
direct
inform
function
activ
detect
antibodi
first
antibodi
respons
detect
human
primari
infect
wnv
decaval
pentamer
igm
isotyp
clinic
case
studi
report
serum
igm
level
appear
day
infect
geabanacloch
et
al
correl
well
analysi
wnvposit
blood
donat
time
infecti
mosquito
bite
index
donat
calcul
use
measur
viral
load
model
viru
doubl
time
princ
et
al
peak
igm
serum
titer
reach
day
infect
persist
month
basi
regress
analysi
igm
level
estim
persist
baselin
averag
month
post
infect
princ
et
al
one
studi
patient
mening
enceph
specif
igm
wnv
measur
day
infect
roehrig
et
al
serum
persist
igm
wnv
unusu
particularli
given
viremia
transient
gener
titer
wnv
antibodi
low
howev
consist
report
serolog
flavivirus
dengu
st
loui
enceph
virus
han
et
al
summer
et
al
somewhat
surprisingli
wnvspecif
igm
appear
csf
detect
serum
soon
viru
detect
csf
geabanacloch
et
al
igm
larg
diffus
across
barrier
bbb
therefor
may
produc
local
b
cell
traffick
csf
binder
griffin
though
inflam
vessel
bbb
integr
compromis
wang
et
al
addit
consist
persist
igm
serum
igm
measur
csf
day
post
infect
kapoor
et
al
extend
mainten
serolog
respons
propos
result
presenc
longliv
plasma
cell
bone
marrow
secret
antibodi
boost
memori
respons
interact
antigen
retain
follicular
dendrit
cell
bystand
stimul
memori
b
cell
heterolog
vaccin
infect
bernasconi
et
al
respons
gener
associ
isotypeswitch
affinitymatur
immunoglobulin
eg
igg
short
serum
halflif
human
igm
day
requir
larger
number
plasma
cell
maintain
serum
level
contrast
switch
isotyp
eg
serum
halflif
day
although
limit
capac
bone
marrow
spleen
accommod
plasma
cell
casses
et
al
manz
radbruch
may
benefit
retain
igm
isotyp
compar
switch
isotyp
cost
effici
maintain
serolog
surveil
could
due
specif
function
igm
constant
region
eg
effici
complement
fixat
detriment
function
switch
isotyp
constant
region
altern
viral
element
could
block
isotyp
switch
interf
tcell
help
reduc
potenti
effect
immun
respons
longitudin
studi
analyz
neutral
potenc
serum
igm
investig
natur
persist
igmsecret
plasma
cell
human
requir
better
understand
relationship
igm
level
wnv
pathogenesi
clinic
outcom
serum
persist
igm
diagnost
implic
wnvreactiv
igm
serum
sampl
gener
regard
confirm
wnv
infect
taken
season
clinic
inform
howev
igm
level
persist
year
overlap
wnv
season
infect
creat
possibl
fals
posit
igm
assay
addit
confound
fail
distinguish
wnv
infect
close
relat
flavivirus
japanes
st
loui
enceph
viru
martin
et
al
isotypeswitch
isoform
immunoglobulin
gener
follow
initi
detect
igm
primari
immun
respons
potent
virusneutr
antibodi
gener
igg
isotyp
reflect
process
affin
matur
hangartn
et
al
human
measur
igg
wnv
appear
serum
second
third
week
infect
time
symptom
would
disappear
princ
et
al
patient
serum
igg
titer
low
find
also
observ
live
attenu
viral
vaccin
test
clinic
trial
monath
et
al
avid
igg
increas
time
respons
secondari
infect
fox
et
al
consist
somat
hypermut
igg
sometim
found
csf
highli
variabl
necessarili
follow
igm
respons
even
igg
measur
serum
geabanacloch
et
al
antigenbind
site
human
ig
deriv
translat
product
two
rearrang
gene
vh
vl
coupl
via
constant
region
vh
gene
made
region
chosen
pool
v
j
similarli
vl
gene
made
two
segment
v
j
vbase
http
vbasemrccpecam
acuk
rearrang
gene
segment
theoret
give
rise
million
combin
certain
underestim
given
extra
variabl
introduc
junction
process
receptor
edit
neuberg
process
somat
hypermut
shm
occur
b
cell
specif
activ
tcell
interact
modifi
antigenbind
site
increas
bind
affin
cognat
antigen
di
noia
neuberg
analys
antibodi
repertoir
gener
infecti
pathogen
reveal
divers
strategi
elicit
protect
immun
case
singl
v
gene
combin
bind
conserv
carbohydr
epitop
domin
immun
respons
kind
restrict
usual
result
surfac
exposur
lowcomplex
antigen
repetit
capsul
polysaccharid
haemophilu
influenza
luca
reason
case
pathogen
display
complex
antigen
surfac
greater
repertoir
divers
observ
one
studi
analyz
antibodi
repertoir
two
donor
boost
tetanu
vaccin
uniqu
combin
calcul
compris
complet
respons
complex
protein
target
tetanu
toxoid
poulsen
et
al
two
studi
analyz
human
antibodi
repertoir
wnv
use
display
approach
one
approach
scfv
phage
librari
construct
b
cell
donor
follow
symptomat
infect
wnv
throsbi
et
al
blood
sampl
taken
convalesc
patient
month
clinic
present
serum
igg
elisa
titer
maximum
month
infect
elisa
titer
differ
patient
correl
neutral
neutral
titer
increas
sampl
time
point
igg
vh
vl
gene
amplifi
patient
pool
combinatori
librari
kramer
et
al
vh
vl
gene
represent
clone
sequenc
unselect
librari
accord
previous
publish
analysi
human
repertoir
de
wildt
et
al
poulsen
et
al
librari
screen
antibodi
bind
wnv
antigen
prepar
includ
either
purifi
inactiv
viru
viruslik
particl
vlp
consist
prm
eprotein
solubl
recombin
eprotein
total
differ
uniqu
vh
gene
defin
level
vh
gene
align
use
identifi
sequenc
v
gene
demonstr
ampl
divers
among
select
scfv
vhvl
combin
contrast
unselect
librari
select
antiwnv
clone
reveal
bia
vs
gene
vs
v
vs
divers
repertoir
consist
antigen
complex
display
wnv
surfac
structur
analysi
flaviviru
envelop
protein
reveal
rel
larg
proport
envelop
protein
solvent
expos
rey
et
al
compar
dens
pack
spike
glycoprotein
vesicular
stomat
viru
vsv
sar
coronaviru
addit
structur
protein
wnv
arrang
complex
pattern
viral
surfac
potenti
creat
antigen
divers
kaufmann
et
al
uniqu
human
mab
identifi
immun
librari
bound
eprotein
singl
mab
reactiv
prm
remain
small
number
bound
unidentifi
target
heterogen
observ
among
panel
term
elisa
immunoprecipit
western
blot
reactiv
eprotein
indic
wnv
mab
bind
divers
number
epitop
contrast
nine
mab
panel
demonstr
activ
microneutr
assay
wnv
observ
due
affin
highest
affin
antibodi
panel
poor
neutral
activ
rather
suggest
restrict
number
epitop
display
wnv
target
neutral
mab
unfortun
studi
repertoir
igm
express
b
cell
examin
would
valuabl
compar
igm
igg
repertoir
convalesc
patient
wnv
infect
given
import
protect
role
antiwnv
igm
anim
model
persist
serum
complementari
set
experi
two
larg
combinatori
librari
built
naiv
donor
extens
screen
antibodi
bind
recombin
wnveprotein
gould
et
al
although
formal
test
assum
none
donor
use
gener
librari
seroposit
wnv
five
uniqu
scfv
wnv
isol
two
neutral
activ
convert
bival
igglik
format
although
poor
recoveri
wnvspecif
binder
librari
could
relat
technic
issu
librari
pan
carri
recombin
eprotein
may
restrict
divers
highaffin
scfv
isol
varieti
target
previou
experi
use
librari
http
researchdcfiharvardedunfcrctaeresearch
mehtaphp
includ
potent
neutral
mab
sar
coronaviru
nanomolar
affin
sui
et
al
may
indic
normal
repertoir
individu
infect
wnv
rearrang
immunoglobulin
specif
wnv
rare
antigen
structur
variou
flavivirus
includ
wnv
extens
studi
effect
develop
vaccin
wnv
depend
sound
knowledg
key
neutral
protect
epitop
wnv
howev
detail
understand
human
immun
system
respond
present
epitop
current
lack
experiment
wnv
infect
antibodi
develop
e
prm
antibodi
eprotein
identifi
neutral
protect
eprotein
mediat
two
import
function
flaviviru
replic
viru
attach
suscept
host
cell
fusion
viral
cellular
membran
mukhopadhyay
et
al
target
protect
antibodi
describ
protein
secret
infect
cell
present
viru
surfac
chung
et
al
henchal
et
al
roehrig
mechan
protect
antibodi
formal
elucid
like
due
antibodydepend
cellular
cytotox
infect
cell
express
surfac
chung
et
al
fine
map
neutral
epitop
eprotein
domain
use
novel
yeast
display
system
oliph
et
al
escap
mutant
gener
beasley
barrett
sanchez
et
al
nmr
wu
et
al
strain
comparison
li
et
al
identifi
sever
critic
residu
requir
neutral
activ
residu
consist
identifi
import
potent
neutral
cluster
around
eprotein
amino
acid
posit
recent
cocrystal
wnv
eprotein
domain
iii
complex
potent
neutral
mab
show
residu
locat
adjac
expos
loop
domain
iii
form
discontinu
epitop
refer
domain
iii
later
ridg
diiilr
nybakken
et
al
sequenc
loop
flavivirus
japanes
enceph
dengu
virus
align
consider
variat
observ
compar
eprotein
whole
nybakken
et
al
consist
observ
eprotein
diii
bind
neutral
antibodi
virustyp
specif
roehrig
sever
studi
map
crossreact
neutral
mab
region
outsid
diii
bind
around
fusion
loop
distal
tip
domain
ii
diifl
crill
chang
goncalvez
et
al
oliph
et
al
stiasni
et
al
antibodi
direct
region
potent
vitro
protect
vivo
diiibind
antibodi
recent
evid
suggest
mani
epitop
partial
occlud
surfac
infecti
viru
part
explain
lack
effici
neutral
activ
oliph
et
al
stiasni
et
al
map
studi
carri
repres
panel
human
mab
isol
wnvimmun
librari
describ
throsbi
et
al
elisa
competit
assay
wnv
antibodi
panel
compet
bind
diiflbind
mab
contrast
compet
diiilrbind
mab
result
vitro
vivo
function
test
human
mab
panel
consist
experiment
system
potent
neutral
protect
mab
exclus
direct
domain
iii
eprotein
wherea
mab
recogn
domain
ii
weak
vitro
neutral
activ
vivo
protect
activ
throsbi
et
al
potent
inhibitori
human
antiwnv
mab
identifi
panel
fine
map
use
yeast
display
demonstr
bind
activ
lost
mutat
residu
indic
epitop
locat
diiilr
oliph
et
al
howev
contrast
potent
mab
bind
region
mutat
posit
affect
bind
suggest
may
bind
novel
overlap
epitop
taken
togeth
data
experi
indic
human
immunodomin
epitop
wnv
situat
predominantli
eprotein
domain
ii
gener
weak
neutral
activ
weakli
immunogen
eprotein
domain
iii
associ
potent
antivir
activ
experiment
evid
suggest
antibodi
eprotein
domain
ii
flavivirus
certain
condit
enhanc
infect
wnv
vitro
nybakken
et
al
pierson
et
al
anim
model
subneutr
concentr
antibodi
relat
flavivirus
result
lower
level
surviv
compar
anim
treat
control
antibodi
hawk
lafferti
administr
nonprotect
yf
mab
time
yf
jev
viru
challeng
shown
enhanc
neurovirul
gould
buckley
human
seriou
hemorrhag
diseas
associ
previou
exposur
heterolog
subtyp
dengu
cardosa
halstead
process
call
antibodydepend
enhanc
ade
thought
result
intern
product
infect
macrophag
myeloid
cell
receptor
cardosa
et
al
iankov
et
al
takada
kawaoka
tirado
yoon
similar
way
complement
fixat
viral
uptak
complement
receptor
macrophag
also
associ
enhanc
infect
cardosa
et
al
tirado
yoon
signific
proport
nonneutr
mab
isol
wnvimmun
repertoir
bound
epitop
depend
homodimer
form
eprotein
particularli
activ
fix
complement
throsbi
et
al
thu
commonli
identifi
antibodi
human
antibodi
repertoir
could
theori
enhanc
infect
via
mechan
allow
viru
intern
larger
number
cell
type
import
note
enhanc
wnv
infect
also
demonstr
vitro
potent
antieprotein
domain
iiineutr
antibodi
low
concentr
neutral
enhanc
activ
overlap
pierson
et
al
howev
find
reproduc
experiment
vivo
engl
diamond
two
studi
one
screen
naiv
human
b
cell
repertoir
infect
gould
et
al
look
b
cell
repertoir
infect
throsbi
et
al
indic
human
immun
respons
skew
toward
eprotein
domain
ii
wnv
potent
neutral
eprotein
domain
iii
antibodi
rare
human
b
cell
repertoir
address
point
analysi
human
serum
sampl
carri
gain
loss
function
wnv
eprotein
mutant
oliph
et
al
convalesc
serum
sampl
screen
variou
time
point
clinic
diseas
demonstr
skew
toward
dii
epitop
compar
diiibind
epitop
although
substanti
variat
observ
averag
rang
total
igg
respons
direct
diii
even
smaller
fraction
potent
neutral
epitop
diiilr
percentag
remark
close
deriv
repertoir
analysi
describ
diii
diiilr
contrast
rang
total
igg
direct
singl
epitop
tip
domain
ii
consist
repertoir
analysi
antibodi
shown
bind
region
throsbi
et
al
second
observ
emerg
clear
differ
respons
experiment
anim
human
wnv
infect
mice
wnv
eproteinspecif
igm
appear
earli
infect
peak
day
declin
rapidli
interestingli
contrast
situat
human
specif
igm
respons
diii
alreadi
present
serum
increas
infect
preinfect
immunoreact
viral
protein
frequent
observ
avramea
gener
ascrib
natur
igm
casali
schettino
ochsenbein
zinkernagel
mice
natur
igm
produc
tindepend
fashion
cell
defin
surfac
express
local
peritoneum
baumgarth
et
al
casali
notkin
natur
antibodi
character
polyspecif
lowaffin
bind
gener
encod
germlin
v
gene
without
much
evid
somat
mutat
natur
antibodi
propos
form
first
line
defens
infect
ochsenbein
zinkernagel
human
exist
specif
lineag
b
cell
produc
natur
antibodi
controversi
date
conclus
demonstr
tindepend
antibodi
respons
carbohydr
antigen
mediat
margin
zone
b
cell
harbor
mutat
v
gene
luca
reason
may
prediversifi
weller
et
al
howev
human
polyreact
immunoreact
ascrib
b
cell
undergon
antigendriven
prolifer
matur
tsuiji
et
al
although
prompt
igm
respons
direct
toward
diiilr
mice
igg
critic
protect
epitop
detect
day
sequenc
analysi
sever
strongli
neutral
murin
mab
bind
diiilr
epitop
show
v
region
germlin
configur
oliph
et
al
circumst
rapid
protect
igg
respons
would
expect
observ
acut
cytopath
virus
bachmann
et
al
possibl
explan
explos
bcell
prolifer
expans
germin
center
antibodi
specif
direct
multipl
immunodomin
di
dii
epitop
simpli
outcompet
restrict
diiilr
epitop
although
delay
robust
murin
igg
respons
observ
diiilr
epitop
indic
noth
intrins
molecular
structur
make
diiilr
nonimmunogen
rather
failur
human
gener
igm
consist
igg
respons
diiilr
may
result
hole
human
antibodi
germlin
repertoir
make
difficult
develop
highaffin
antibodi
diiilr
epitop
phenomenon
report
immun
respons
lymphocyt
choriomening
viru
lcmv
mice
lcmv
shown
effect
immunogen
transgen
mice
alreadi
bear
highaffin
cognat
receptor
infect
wildtyp
mice
infect
result
poor
antibodi
respons
princip
neutral
epitop
hangartn
et
al
specul
coevolut
lcmv
host
select
neutral
epitop
recogn
high
avid
antibodi
murin
germin
repertoir
hangartn
et
al
unlik
wnv
evolv
analog
manner
mammal
includ
human
deadend
host
viru
hay
gubler
bcell
immunoglobulin
receptor
diiilr
may
simpli
absent
repertoir
mani
individu
rare
outcompet
antigen
antibodi
immunodomin
epitop
altern
conform
epitop
diiilr
may
mimic
antigen
structur
human
selfprotein
case
b
cell
express
highavid
ig
receptor
crossreact
epitop
would
purg
neg
select
bcell
differenti
contribut
humor
immun
respons
wnv
healthi
individu
appear
abl
mount
robust
protect
respons
wnv
infect
rel
small
number
infect
display
clinic
sign
even
smaller
number
develop
seriou
symptom
innat
resist
mechan
interferon
secret
signal
like
explain
much
protect
activ
experiment
model
humor
immun
play
import
role
protect
lethal
infect
howev
protect
role
antibodi
play
human
less
clear
studi
perform
date
suggest
sever
deficit
human
antibodi
respons
natur
wnv
infect
compar
experiment
model
particular
antibodi
respons
critic
potent
neutral
epitop
eprotein
domain
iii
envelop
protein
develop
minor
individu
compar
immunodomin
poorli
neutral
epitop
anoth
anomal
observ
persist
igm
serum
level
could
result
viral
interfer
isotyp
switch
deficit
human
antibodi
respons
wnv
infect
may
impact
protect
diseas
innat
respons
weaken
owe
age
immunosuppress
analysi
human
antibodi
respons
wnv
like
help
direct
develop
effect
safe
vaccin
target
highrisk
group
elderli
current
find
suggest
vaccin
development
effort
focu
increas
immunogen
eprotein
domain
iii
maintain
broad
coverag
wnv
strain
prevent
escap
within
individu
due
format
quasispeci
